Valuation Chugai Pharmaceutical Co., Ltd.

Equities

4519

JP3519400000

Pharmaceuticals

Delayed Japan Exchange Other stock markets 14:30:00 12/03/2026 HKT			5-day change	1st Jan Change
9,429.00 ^JPY	-0.38%		-3.06%	+14.39%

02-24	Sarepta Therapeutics, Inc. Announces Commercial Launch of ELEVIDYS in Japan	CI
02-24	Sarepta Therapeutics Says Elevidys Available in Japan for Duchenne Muscular Dystrophy	MT

Company Valuation: Chugai Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	9,045,924	6,141,311	5,540,406	8,789,053	11,516,953	15,576,678	15,576,678	-
Change	-	-32.11%	-9.78%	58.64%	31.04%	35.25%	0%	-
Enterprise Value (EV) ¹	8,667,304	5,669,311	5,051,408	8,050,071	10,520,608	13,138,942	14,499,256	14,281,210
Change	-	-34.59%	-10.9%	59.36%	30.69%	24.89%	-1.23%	-1.5%
P/E ratio	42.1x	20.3x	14.8x	27x	29.7x	31.3x	31.5x	27.4x
PBR	9.23x	5.17x	3.89x	5.41x	6.06x	6.7x	6.95x	6.06x
PEG	-	0.5x	0.6x	-2.1x	1.6x	2.6x	2x	1.8x
Capitalization / Revenue	11.5x	6.14x	4.4x	7.91x	9.84x	10.8x	11.3x	10.5x
EV / Revenue	11x	5.67x	4.01x	7.24x	8.99x	10.4x	10.5x	9.59x
EV / EBITDA	26.1x	12.3x	8.93x	17.1x	18.3x	20.4x	20.5x	17.8x
EV / EBIT	28.8x	13.4x	9.47x	18.3x	19.4x	21.9x	21.4x	18.4x
EV / FCF	81.2x	35.3x	27.7x	21.6x	47.8x	71x	31.8x	27.5x
FCF Yield	1.23%	2.83%	3.61%	4.63%	2.09%	1.41%	3.15%	3.64%
Dividend per Share ²	55	76	78	80	98	272	136.9	151.6
Rate of return	1%	2.03%	2.32%	1.5%	1.4%	3.3%	1.45%	1.6%
EPS ²	130.7	184.3	227.6	197.8	235.4	263.7	300.2	345.8
Distribution rate	42.1%	41.2%	34.3%	40.4%	41.6%	103%	45.6%	43.8%
Net sales ¹	786,900	999,800	1,259,946	1,111,367	1,170,611	1,257,900	1,376,191	1,489,553
EBITDA ¹	332,600	459,100	565,376	470,914	573,667	643,900	707,873	802,086
EBIT ¹	301,200	421,900	533,309	439,174	542,002	598,800	678,023	776,079
Net income ¹	214,700	303,000	374,429	325,472	387,317	434,000	494,071	568,931
Net Debt ¹	-378,620	-472,000	-488,998	-738,982	-996,345	-426,602	-1,077,422	-1,295,467
Reference price ²	5,503.00	3,735.00	3,368.00	5,342.00	6,999.00	9,465.00	9,465.00	9,465.00
Nbr of stocks (in thousands)	1,643,817	1,644,260	1,645,014	1,645,274	1,645,514	1,645,713	1,645,713	-
Announcement Date	4/2/21	3/2/22	2/2/23	1/2/24	30/1/25	29/1/26	-	-

¹JPY in Million²JPY

Estimates

P/E ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHUGAI PHARMACEUTICAL CO., LTD.	36.39x	11.77x	23.14x	2.68%	98.08B
ELI LILLY AND COMPANY	29.39x	11.07x	22.23x	0.66%	893B
JOHNSON & JOHNSON	25.78x	6x	16.34x	2.18%	586B
ABBVIE INC.	24.73x	6.77x	13.58x	3.04%	403B
ROCHE HOLDING AG	17.77x	4.33x	10.71x	3.05%	338B
ASTRAZENECA PLC	24.42x	5.09x	14.09x	1.71%	301B
NOVARTIS AG	21.17x	5.7x	14.1x	2.84%	297B
MERCK & CO., INC.	27.16x	4.76x	14.89x	2.9%	287B
AMGEN INC.	25.41x	6.42x	11.43x	2.66%	204B
GILEAD SCIENCES, INC.	20.24x	6.16x	11.14x	2.23%	181B
Average	25.25x	6.81x	15.16x	2.4%	358.73B
Weighted average by Cap.	25.41x	7.18x	16.12x	2.1%